HK1220609A1 - 種用於治療肌萎縮性側索硬化症的β受體阻滯劑的 -對映體富集組合物 - Google Patents

種用於治療肌萎縮性側索硬化症的β受體阻滯劑的 -對映體富集組合物

Info

Publication number
HK1220609A1
HK1220609A1 HK16108630.1A HK16108630A HK1220609A1 HK 1220609 A1 HK1220609 A1 HK 1220609A1 HK 16108630 A HK16108630 A HK 16108630A HK 1220609 A1 HK1220609 A1 HK 1220609A1
Authority
HK
Hong Kong
Prior art keywords
lateral sclerosis
amyotrophic lateral
enantiomerically enriched
beta blockers
treating amyotrophic
Prior art date
Application number
HK16108630.1A
Other languages
English (en)
Inventor
安德魯.
.科茨
斯特凡.安柯
約翰恩.斯普林格
Original Assignee
Coats Andrew J S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coats Andrew J S filed Critical Coats Andrew J S
Publication of HK1220609A1 publication Critical patent/HK1220609A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16108630.1A 2013-03-14 2016-07-20 種用於治療肌萎縮性側索硬化症的β受體阻滯劑的 -對映體富集組合物 HK1220609A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361786235P 2013-03-14 2013-03-14
PCT/AU2014/000274 WO2014138814A1 (en) 2013-03-14 2014-03-14 S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis

Publications (1)

Publication Number Publication Date
HK1220609A1 true HK1220609A1 (zh) 2017-05-12

Family

ID=51535623

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108630.1A HK1220609A1 (zh) 2013-03-14 2016-07-20 種用於治療肌萎縮性側索硬化症的β受體阻滯劑的 -對映體富集組合物

Country Status (11)

Country Link
US (3) US10449166B2 (zh)
EP (1) EP2968227B1 (zh)
CN (1) CN105358140A (zh)
AU (1) AU2014231724B2 (zh)
CA (1) CA2906206C (zh)
DK (1) DK2968227T3 (zh)
ES (1) ES2725893T3 (zh)
HK (1) HK1220609A1 (zh)
PL (1) PL2968227T3 (zh)
PT (1) PT2968227T (zh)
WO (1) WO2014138814A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3015313A1 (en) 2016-02-26 2017-08-31 Actimed Therapeutics Ltd S-enantiomerically enriched compositions of beta blockers for treating muscle weakness
HUP1800298A1 (hu) * 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE222231T1 (de) * 1996-09-18 2002-08-15 Daiso Co Ltd Verfahren zur herstellung von 3-amino-2-hydroxy-1-propylethern
US20050143378A1 (en) * 2003-12-29 2005-06-30 Yun Anthony J. Treatment of conditions through pharmacological modulation of the autonomic nervous system
US20070021421A1 (en) * 2005-07-25 2007-01-25 Hampton Thomas G Measurement of gait dynamics and use of beta-blockers to detect, prognose, prevent and treat amyotrophic lateral sclerosis
CN101323580A (zh) * 2008-07-25 2008-12-17 河北科技大学 手性芳氧丙醇胺类化合物及其盐的合成方法
GB0907350D0 (en) * 2009-04-29 2009-06-10 Myotec Therapeutics Ltd Methods
JP2015526423A (ja) * 2012-07-25 2015-09-10 サイオクサス セラピューティクス リミテッド カヘキシア及びサルコペニアを治療するためのs−ピンドロールの使用

Also Published As

Publication number Publication date
US10449166B2 (en) 2019-10-22
US11938102B2 (en) 2024-03-26
US20200054585A1 (en) 2020-02-20
AU2014231724B2 (en) 2018-05-10
US11007158B2 (en) 2021-05-18
US20160022613A1 (en) 2016-01-28
NZ713051A (en) 2020-09-25
ES2725893T3 (es) 2019-09-30
CA2906206A1 (en) 2014-09-18
CN105358140A (zh) 2016-02-24
EP2968227A1 (en) 2016-01-20
CA2906206C (en) 2021-09-14
US20210330615A1 (en) 2021-10-28
EP2968227B1 (en) 2019-02-13
DK2968227T3 (da) 2019-05-13
PT2968227T (pt) 2019-05-30
AU2014231724A1 (en) 2015-10-29
EP2968227A4 (en) 2016-10-26
WO2014138814A1 (en) 2014-09-18
PL2968227T3 (pl) 2019-09-30

Similar Documents

Publication Publication Date Title
IL261725A (en) New preparations for the treatment of lateral column sclerosis in the spine
GB2544342B (en) Compositions for application to wounds
HK1258223A1 (zh) 用於治療肌萎縮性脊髓側索硬化症的新組合物
SG11201602596UA (en) Stabilized efinaconazole compositions
HK1214618A1 (zh) 含有透明質酸的穩定化組合物
EP2895606A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF AMYOTROPHER LATERAL SCLEROSIS (ALS)
PL3199613T3 (pl) Kompozycje oczyszczające
PL3021839T3 (pl) Kompozycje do leczenia zwłóknienia
EP2906580A4 (en) TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
PL3086751T3 (pl) Stabilizowane kompozycje cyny
GB2511350B (en) Skincare compositions
GB201320409D0 (en) Prebiotic composition
GB201305556D0 (en) Skincare compositions
PL3021840T3 (pl) Kompozycje do zapobiegania reakcji alergicznej
PT2964381T (pt) Composição para a produção de massas de borracha de silicone
EP2814479A4 (en) METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS
HK1220609A1 (zh) 種用於治療肌萎縮性側索硬化症的β受體阻滯劑的 -對映體富集組合物
HRP20182110T1 (hr) Sastav spojeva tiakumicina
GB2515071B (en) Novel composition for a foot-soaking bath
HK1203406A1 (zh) 用於治療肌萎縮側索硬化症的新組合物
HK1204865A1 (zh) 消滅棘手的有害動物的組合物
SI2819664T1 (sl) Novi sestavki za zdravljenje amiotrofične lateralne skleroze
GB201315461D0 (en) Composition of phosphonates
ZA201401705B (en) Coating composition for application to new plasterwork
GB201303721D0 (en) Compositions for treatment of sleep disorders